CSIMarket
 


Enanta Pharmaceuticals Inc   (ENTA)
Other Ticker:  
 
 

ENTA's Net Income Growth by Quarter and Year

Enanta Pharmaceuticals Inc 's Net Income results by quarter and year




ENTA Net Income (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
IV Quarter September - 9.19 27.42 36.51
III Quarter June - 7.04 20.29 -8.43
II Quarter March -6.01 4.15 12.56 -5.39
I Quarter December 13.44 26.01 11.69 -4.98
FY   7.44 46.39 71.96 17.71



ENTA Net Income second quarter 2020 Y/Y Growth Comment
Enanta Pharmaceuticals Inc in the second quarter recorded net loss of $ -6.01 millions.

Looking into second quarter results within Major Pharmaceutical Preparations industry 28 other companies have achieved higher Net Income growth. While Enanta Pharmaceuticals Inc ' s Net Income no change of % ranks overall at the positon no. 1639 in the second quarter.




ENTA Net Income ( Y/Y Growth %) 2020
2019 2018 2017
IV Quarter September - -66.48 % -24.9 % -
III Quarter June - -65.3 % - -
II Quarter March - -66.96 % - -
I Quarter December -48.33 % 122.5 % - -
FY   - -35.53 % 306.32 % -18.24 %

Financial Statements
Enanta Pharmaceuticals Inc 's second quarter 2020 Net Income $ -6.01 millions ENTA's Income Statement
Enanta Pharmaceuticals Inc 's second quarter 2019 Net Income $ 4.15 millions Quarterly ENTA's Income Statement
New: More ENTA's historic Net Income Growth >>


ENTA Net Income (Quarter on Quarter Growth %)

2020
2019 2018 2017
IV Quarter September - 30.54 % 35.14 % -
III Quarter June - 69.64 % 61.54 % -
II Quarter March - -84.04 % 7.44 % -
I Quarter December 46.25 % -5.14 % -67.98 % -
FY (Year on Year)   - -35.53 % 306.32 % -18.24 %




Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #121
Overall #1639

Net Income Y/Y Growth Statistics
High Average Low
137.58 % 7.47 % -48.12 %
(Dec. 30, 2014)   (March 31, 2016)
Net Income second quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #29
Healthcare Sector #121
Overall #1639
Net Income Y/Y Growth Statistics
High Average Low
137.58 % 7.47 % -48.12 %
(Dec. 30, 2014)   (March 31, 2016)

Net Income by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Enanta Pharmaceuticals Inc 's Q/Q Net Income Growth


Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENTA's II. Quarter Q/Q Net Income Comment
Recent results of -6.01 millions by Enanta Pharmaceuticals Inc look even less good considering the net loss 13.44 millions in the previous quarter.

Within Major Pharmaceutical Preparations industry Enanta Pharmaceuticals Inc achieved highest sequential Net Income growth. While Enanta Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Net Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


ENTA's II. Quarter Q/Q Net Income Comment
II. Quarter 2020 accomplishment of -6.01 millions by Enanta Pharmaceuticals Inc look even worse if you take a look at 13.44 millions a quarter before.

Within Major Pharmaceutical Preparations industry Enanta Pharmaceuticals Inc achieved highest sequential Net Income growth. While Enanta Pharmaceuticals Inc 's Net Income growth quarter on quarter, overall rank is .


Enanta Pharmaceuticals Inc 's 12 Months Net Income Growth Year on Year


Net Income TTM Growth

12 Months Ending
(Mar 31 2020)
12 Months Ending
(Dec 31 2019)
12 Months Ending
(Sep 30 2019)
12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
Cumulative Net Income 12 Months Ending $ 23.67 $ 33.82 $ 46.38 $ 64.61 $ 77.86
Y / Y Net Income Growth (TTM) -69.61 % -60.81 % -35.54 % -20.28 % 48.79 %
Year on Year Net Income Growth Overall Ranking # 1583 # 1719 # 1449 # 1614 # 576
Seqeuential Net Income Change (TTM) -30.02 % -27.1 % -28.21 % -17.02 % -9.75 %
Seq. Net Income Growth (TTM) Overall Ranking # 1639 # 2169 # 1681 # 1895 # 1759




Cumulative Net Income growth Comment
Enanta Pharmaceuticals Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -69.61% year on year, at Mar 31 2020 compare to the -60.81% decrease at Dec 31 2019. If the Enanta Pharmaceuticals Inc 's fiscal year would end at Mar 31 2020, annual Net Income would be $24 millions.

In the Healthcare sector 101 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1583, from total ranking in previous quarter at 1719.

Net Income TTM Q/Q Growth Statistics
High Average Low
137.58 %
7.47 %
-48.12 %
 

Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 29
Healthcare Sector # 102
Overall # 1583

Net Income TTM Y/Y Growth Statistics
High Average Low
306.3 %
3.92 %
-72.57 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 121
S&P 500 # 1639
Cumulative Net Income growth Comment
Enanta Pharmaceuticals Inc 's cumulative 12 months Net Income continue to drop, but on the faster rate at -69.61% year on year, at Mar 31 2020 compare to the -60.81% decrease at Dec 31 2019. If the Enanta Pharmaceuticals Inc 's fiscal year would end at Mar 31 2020, annual Net Income would be $24 millions.

In the Healthcare sector 101 other companies have achieved higher trailing twelve month Net Income growth. While Total ranking has impoved so far to 1583, from total ranking in previous quarter at 1719.

Net Income TTM Q/Q Growth Statistics
High Average Low
137.58 %
7.47 %
-48.12 %
 


Net Income TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 29
Healthcare Sector # 102
Overall # 1583

Net Income TTM Y/Y Growth Statistics
High Average Low
306.3 %
3.92 %
-72.57 %
 


Net Income TTM Q/Q Growth Company Ranking
Within: No.
Industry # 29
Sector # 121
S&P 500 # 1639




Other Net Income Growth
Major Pharmaceutical Preparations Industry Net Income Growth Trends and Statistics
Healthcare Sector Net Income Growth Statistics
Net Income Growth Trends for overall market
ENTA's Net Income Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Net Income Growth
Lowest Ranking Net Income Growth
Net Income Growth for ENTA's Competitors
Net Income Growth for Enanta Pharmaceuticals Inc 's Suppliers
Net Income Growth for ENTA's Customers

You may also want to know
ENTA's Annual Growth Rates ENTA's Profitability Ratios ENTA's Asset Turnover Ratio ENTA's Dividend Growth
ENTA's Roe ENTA's Valuation Ratios ENTA's Financial Strength Ratios ENTA's Dividend Payout Ratio
ENTA's Roa ENTA's Inventory Turnover Ratio ENTA's Growth Rates ENTA's Dividend Comparisons



Companies with similar Net Income drop for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Net Income for the quarter ending Mar 31 2020
Biogen Inc -1.15 %$ -1.150 millions
Baxter International Inc -4.03 %$ -4.035 millions
Iradimed Corporation -4.14 %$ -4.137 millions
Alexion Pharmaceuticals Inc -5.15 %$ -5.154 millions
Hill rom Holdings Inc -5.25 %$ -5.253 millions
Atrion Corp -5.72 %$ -5.722 millions
U s Neurosurgical Holdings Inc -5.91 %$ -5.914 millions
Pra Health Sciences Inc -8.13 %$ -8.125 millions
Amgen Inc -8.38 %$ -8.384 millions
Charles River Laboratories International inc -8.71 %$ -8.711 millions
Phibro Animal Health Corp -9.08 %$ -9.078 millions
Lemaitre Vascular Inc -9.65 %$ -9.650 millions
Mettler Toledo International Inc -12.24 %$ -12.245 millions
Pfizer Inc -12.32 %$ -12.317 millions
Encompass Health Corporation -13.18 %$ -13.179 millions
Haemonetics Corporation -15.41 %$ -15.412 millions
Abbott Laboratories -16.07 %$ -16.071 millions
Bio techne Corp -18.41 %$ -18.413 millions
Bio rad Laboratories Inc -20.72 %$ -20.722 millions
Gilead Sciences Inc -21.85 %$ -21.850 millions
Illumina Inc -22.77 %$ -22.768 millions
Universal Health Services Inc -39.15 %$ -39.149 millions
Biotelemetry Inc -39.16 %$ -39.161 millions
Quest Diagnostics Inc -39.77 %$ -39.773 millions
Hca Healthcare Inc -40.90 %$ -40.898 millions
Nuvasive Inc -43.55 %$ -43.554 millions
National Vision Holdings Inc -44.10 %$ -44.105 millions
Icu Medical Inc -45.69 %$ -45.693 millions
Abiomed Inc -57.01 %$ -57.007 millions
Pacific Health Care Organization Inc -60.86 %$ -60.857 millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

ARL's Profile

Stock Price

ARL's Financials

Business Description

Fundamentals

Charts & Quotes

ARL's News

Suppliers

ARL's Competitors

Customers & Markets

Economic Indicators

ARL's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071